SCHEMBL4846498

SCHEMBL4846498

COc1ccc2c(c1)/C(=C/C(=O)c1ccc(NC(=O)c3ccc(Cl)cc3)cc1)NC(C)(C)C2

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.44
RXFP1 Q9HBX9 1/20 0.44
GSK3B P49841 1/20 0.44
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
ALOX15 P16050 1/20 0.43
PDGFRB P09619 1/20 0.43
FGFR1 P11362 1/20 0.43
KDR P35968 1/20 0.43
MAPT P10636 5/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 2/20 0.41
F10 P00742 3/20 0.41
F2 P00734 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846510 1.00 TP53 (0.44) TP53RXFP1GSK3BMEN1KMT2A
SCHEMBL4839109 0.94 RAB9A (0.49) TP53RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL4839102 0.94 RAB9A (0.49) TP53RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL4838356 0.94 TAS1R3 (0.41) TP53RXFP1GSK3BMEN1KMT2A
SCHEMBL4838367 0.94 TAS1R3 (0.41) TP53RXFP1GSK3BMEN1KMT2A
SCHEMBL4835216 0.92 NPC1 (0.51) TP53RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL4837859 0.92 AR (0.44) TP53RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL4835233 0.92 NPC1 (0.51) TP53RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL4840832 0.92 NPC1 (0.49) TP53GSK3BMEN1KMT2ASMN1; SMN2
SCHEMBL4844449 0.92 KMT2A (0.47) TP53RXFP1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 TP53 2237/4885RXFP1 645/4885GSK3B 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.